Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.10.0.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 5,560 $ 123,476,102 $ (65,698,101) $ 57,783,561
Balance, shares at Dec. 31, 2017 55,603,427      
Issuance of common stock, net of issuance costs of $464,680 $ 150 11,235,170 11,235,320
Issuance of common stock, net of issuance costs of $464,680 shares 1,500,000      
Stock-based compensation expense 5,659,928 5,659,928
Issuance of common stock upon exercise of stock options $ 13 337,632 $ 337,645
Issuance of common stock upon exercise of stock options, shares 129,069     129,069
Issuance of common stock upon exercise of warrants $ 1 4,999 $ 5,000
Issuance of common stock upon exercise of warrants, shares 5,000      
Fair value of warrant issued in connection with Investment Agreement 6,215,225 6,215,225
Net loss (38,365,947) (38,365,947)
Balance at Sep. 30, 2018 $ 5,724 $ 146,929,056 $ (104,064,048) $ 42,870,732
Balance, shares at Sep. 30, 2018 57,237,496